An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers
Abdullah S. Madhun(Norwegian Institute of Marine Research), Rebecca Jane Cox(Haukeland University Hospital), Haakon Sjursen(Haukeland University Hospital), Åsne Jul‐Larsen(University of Bergen), Gabriel Kristian Pedersen(Statens Serum Institut), Per Espen Akselsen(Haukeland University Hospital), Jane Kristin Nøstbakken(University of Bergen), John Wood(Women's and Children's Hospital), Ingrid Smith(Haukeland University Hospital), Diane Major(National Institute for Biological Standards and Control), Mona V. Nilsen(University of Bergen), Kristin G. I. Mohn(Haukeland University Hospital), Signe Svindland(University of Bergen)
Cited by 63
Related Papers
Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
|Vaccine|2004|156
Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
|Emerging infectious diseases|2009|150
A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
|Influenza and Other Respiratory Viruses|2007|148